CHICAGO--(BUSINESS WIRE)-- Igenbio, Inc. announced today the expansion of metagenomics service offerings to include microbial community profiling, and microbial community metabolic analysis. Igenbio’s microbial community analysis service helps answer pressing questions in microbiome, environmental, and clinical studies. Igenbio’s scientists’ expertise streamlines the development of custom assays which efficiently answer specific research questions. Analysis offerings range from rRNA analysis, to whole metagenome sequencing, and qPCR. Igenbio’s flagship product ERGO 2.0 enables researchers to deepen the analysis of expression data on interactive exportable metabolic pathway visualizations enabling industrial, academic, and medical scientists to rapidly discover and develop diagnostic biomarkers.

Built on a robust and well-curated genomic pathway database and comparative genome tools, ERGO 2.0 offers a unique single web-based platform for Metagenomics applications including phylogenetic analysis, quantitative and relative abundance estimation, transcriptomics with statistical integration of relative abundance, alpha diversity, richness plots, and more. ERGO 2.0 also provides meta transcriptomics data integration and overlay on metabolic and non-metabolic pathways with statistical analysis, linkage, clustering, etc. “One can use ERGO without being an expert in metagenomics, bioinformatics, or statistics and get answers to who is there, in what proportion, what are they are doing? ERGO does all the analysis and provides useful results. This is especially useful for non-culturable organisms,” says Vinayak Kapatral, Ph.D., President CEO at Igenbio, Inc.

About Igenbio

Chicago-based Igenbio, Inc. specializes in research in microbial genomics, biochemistry, and gene expression. Igenbio, Inc. serves a broad customer base across industry, academic and government institutions. ERGO 2.0 integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, biochemical with genome and gene-centric tools for genome research.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180213006609/en/